Month: September 2020

EURONEXT AND CDP EQUITY CONFIRM EXCLUSIVE TALKS WITH LSEG TO ACQUIRE BORSA ITALIANAAmsterdam, Brussels, Dublin, Lisbon, Oslo, Paris and Rome – 18 September 2020 – Euronext and CDP Equity (“CDPE”, 100% owned by Cassa Depositi e Prestiti) confirm they have entered into exclusive talks with London Stock Exchange Group plc (“LSEG”) to acquire Borsa Italiana group, together with Intesa Sanpaolo. There can be no certainty that this will lead to a transaction.The proposed combination of Borsa Italiana and Euronext would create a leading player in continental European capital markets. This transformational project would position the newly formed group to deliver the ambition of further building the backbone of the Capital Markets Union in Europe, while at the same time supporting local economies.Italy, through Borsa Italiana, would become the...

SalMar ASAs subsidiary Arnarlax AS, who through its subsidiary Arnarlax Ehf has farming activity on Iceland, has engaged DNB Markets as Sole Global Coordinator in connection with a potential private placement and listing on Merkur Market during 2020.SalMar does not consider a sale in connection with the transaction and will maintain an ownership interest of more than 50% in Arnarlax following the private placement.For additional information reference is made to the notice published by Arnarlax which can be found at www.arnarlax.isThis information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

SalMar ASA sitt datterselskap Arnarlax AS, som gjennom sitt datterselskap Arnarlax Ehf driver med oppdrettsvirksomhet på Island, har engasjert DNB Markets som tilrettelegger i forbindelse med en mulig rettet emisjon, samt notering av selskapets aksjer på Merkur Market i løpet av 2020.SalMar vurderer ikke nedsalg i forbindelse med transaksjonen og vil opprettholde en eierandel på over 50% i Arnarlax etter transaksjonen.For ytterligere informasjon henvises det til melding sendt ut av Arnarlax som man kan finne på www.arnarlax.isDenne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12.

The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus.The test  targets antibodies against the spike protein. This is the focus of vaccines in development and convalescent plasma therapy.1Using the Elecsys Anti-SARS-COV-2 S antibody test, together with the Elecsys Anti-SARS-CoV-2* test launched in May, can help to more effectively determine the percentage of a population who already have antibodies against SARS-COV-2.Basel, 18 September 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its Elecsys® Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark. Roche has filed for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA).Launching COVID-19 diagnostic tests for active...

                                                                                                                                                            Dr. Jean-Christophe Rufin appointed President of the Sanofi Espoir Corporate FoundationPARIS – September 18, 2020 – Sanofi today announced the appointment of Dr. Jean-Christophe Rufin as President of the Sanofi Espoir Corporate Foundation. Jean-Christophe Rufin succeeds Xavier Darcos, who presided over the Foundation since 2015.“We are delighted that Dr. Jean-Christophe Rufin has accepted to serve as  President of the Sanofi Espoir Foundation”, said Serge Weinberg, President of Sanofi. “His experience as both a physician and diplomat gives him a broad expertise in humanitarian and public health issues around the world. He will enable us to step up our response...

 Le Dr Jean-Christophe Rufin est nommé Présidentde la Fondation d’entreprise Sanofi EspoirParis (France) – Le 18 septembre 2020 – Sanofi annonce la nomination du Dr Jean-Christophe Rufin à la présidence de la Fondation d’entreprise Sanofi Espoir. Jean-Christophe Rufin succède à Xavier Darcos, qui présidait la Fondation depuis 2015.« Nous sommes très heureux que le Dr Jean-Christophe Rufin ait accepté de présider la Fondation Sanofi Espoir », déclare Serge Weinberg, Président de Sanofi. « Son expérience de médecin et de diplomate en fait un grand connaisseur des questions humanitaires et de santé publique dans le monde. Il nous permettra de renforcer notre réponse face à la détresse sanitaire des populations vulnérables. Par son œuvre littéraire, il a fait largement la preuve de son engagement humaniste et de sa qualité d’observateur des...

 Saint-Herblain (France), September 18, 2020 – Valneva SE (“Valneva”), a specialty vaccine company focused on prevention of diseases with major unmet needs, today announced the retirement of its Chief Financial Officer, David Lawrence, at the end of 2020.The Company has initiated a search process with a leading global recruitment agency to identify a new CFO, aiming for an on-boarding in the first quarter of 2021.Until the end of the year, David will manage a handover process to ensure a smooth transition with Manfred Tiefenbacher, VP Finance, who will assume responsibility for all operational finance matters.In addition, David has agreed to continue to support Valneva’s CEO in an advisory capacity in the early part of 2021.Thomas Lingelbach, Chief Executive Officer of Valneva, said, “We would like to thank David for his great contributions...